13+ Years of Biological Manufacturing for a Healthier Future

Founded in 2013, VDK focuses on the core of synthetic biology and has established itself as a platform enterprise with a comprehensive full-chain in this industrialization track.

VDK maintains full, independent control over its operations — from enzyme discovery and optimization →metabolic pathway engineering→strain development→pilot-scale fermentation and separation → large-scale industrial production → final product sales.

VDK manufactures all products by utilizing fully self-funded fixed assets and focuses on four major areas: dietary supplements, natural pigments, fragrances, API, and pharmaceutical intermediates.

Leveraging its independently developed microbial cell factory technology, VDK is a global pioneer in the large-scale biomanufacturing of natural products, including 5-HTP, sclareol glycol, and astaxanthin oleoresin. Furthermore, with a portfolio of ten industrialized products, VDK leads the industry in efficiency for technology transfer and industrialization.